Medtronic's CoreValve "a 2014 product" for U.S., looks good in clinical trials European Society of Cardiology Congress 2011 MassDevice - Medical Device Industry News: Medtronic Inc. (NYSE:MDT) touted the latest results from studies of its CoreValve transcatheter aortic valve implantation system, which is two years behind competitor Edwards Lifesciences Corp. (NYSE:EW) in the U.S. market, at the European Society of Cardiology Congress 2011 conference in Paris today.
